openPR Logo
Press release

Biologic Response Modifiers Market Trends, Regulations And Competitive Landscape Outlook to 2027

11-23-2018 01:16 PM CET | Health & Medicine

Press release from: Future Market Insights

Biologic Response Modifiers Market Trends, Regulations

Biologic Response Modifiers are the substances that modulate the immune response by either increasing or decreasing the immunogenic effect. These are used in immunotherapy or biological therapy for enhancing the activity of immune system to fight infection and disease. These substances are naturally produced in small amounts in the body but some of them such as interleukins, monoclonal antibodies, inetrferons and colony stimulating factors are now being manufactured in large units by the pharmaceutical industries. Depending on the disease type, synthetic Biologic Response Modifiers mimics the natural cytokines or inhibitors against a receptor and thus been used in the treatment to restore, boost or dampen the host immune response. Various research studies has increased the knowledge regarding the biological agents and the effective targets are being identified.

Increasing prevalence of cancer and autoimmune diseases worldwide and upsurge in the success rates of immunotherapy treatment is going to increase the demand of Biologic Response Modifiers. Recently in 2015, a Biologic Response Modifiers Taltz (ixekizumab) is launched by Eli Lilly in Europe which made $261m in 2015.

Request Sample Report @

Biologic Response Modifiers Market: Drivers & Restraints

Biologic Response Modifiers Market is likely to proliferate in the future as per current trends of increase in the number of cancer patients and autoimmune disorder cases across the globe. Immunotherapy is considered an effective treatment for patients with different types of cancer that are resistant to chemotherapy and radiation treatment. Some of the side effects such as increased risk of certain serious and opportunistic infections for patients receiving these Biologic Response Modifiers therapeutic agents, especially the risks of TB and viral infections restraints their market to grow. Some regulatory issues related to the manufacturing and export also limits the market to expand worldwide. High costs of biologics restricts its availability to all the section of population. Rituxan is one of the FDA approved Biologic Response Modifier drug having an average monthly cash price of more than $5000.

Point-of-Care Genetic Testing Market: Segmentation

Segmentation by Product Type

Colony stimulating factors
Tyrosine kinase inhibitors
Angiogenic Inhibitors
Monoclonal antibodies
Tumor Vaccines

Segmentation by Treatment Type

Autoimmune Diseases

Segmentation by Distribution Channels

Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies

Biologic Response Modifiers Market: Overview

Biologic Response Modifiers have become an important component for the effective management of patients with a variety of autoimmune/inflammatory conditions and cancer. It reduces the side-effects of various cancer treatments, which is favored by patients. Market for Biologic Response Modifiers has increased since the last decade with dozens of drugs been approved by FDA and several research studies in this area. Not only was biologic utilization growing, but the drug prices were also rising fast with a trend of more than 45%. Hefty prices and the increasing demand generated huge revenues for biopharmaceutical companies. The last decade has witnessed the development of various Biologic Response Modifiers, such as mABs, IFNs, TNF, ILs, CSFs, and antitumor vaccines but still there are many more opportunities to be explored. Increase in the clinical trials also expect more drugs in pipeline and thus the market will proliferate.

Biologic Response Modifiers Market: Region-wise Outlook

Geographically, North America dominates the market, followed by Western Europe and Asia Pacific. Presence of large number of biological drug and vaccine manufacturers, high per capita income, affordable treatment facility and good reimbursement scenario for life-threatening diseases proliferates the growth in North America and Western Europe segment. NIH estimates up to 23.5 million Americans have an Auto Immune Disease and cancer affects up to 9 million Americans. Western Europe is the second largest market from both the demand side and supply side scenario. Asia pacific is expected to grow at a highest rate due to increasing prevalence of cancer patient, improvement in the healthcare facilities, more establishment of pharmaceutical companies and growing number of insurance coverage. In Asia-Pacific, China has marketed the presence of large number of patients with autoimmune disorder.

Request to View TOC @

Biologic Response Modifiers Market: Key Players

Some of the global key players in the market includes AbbVie Inc., Swedish Orphan Biovitrum, Amgen, Bristol-Myers Squibb, Novartis, Janssen Inc., Roche Holding AG, Merck & Co., Eli Lilly &Co., Biogen and many others.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Future Market Insights
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologic Response Modifiers Market Trends, Regulations And Competitive Landscape Outlook to 2027 here

News-ID: 1395499 • Views: 187

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases

More Releases for Biologic

Biologic Injectors Market Insights, Forecast to 2028
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases. Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used
Biologic and Medical Imaging Reagents: Global Healthcare Update 2018
Press Release – 10 Jan 2019 Research and Development News -- . . Latest Update "Biologic and Medical Imaging Reagents: Global Markets" with Industries Survey | Global Current Growth and Future. ' ' Report Highlights The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the
Biologic Therapeutics Market Insights & Outlook on Industry 2025
Global Biologic Therapeutics Market: Snapshot The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics. Any pharmaceutical drug product manufactured from semi-synthesized and biological sources is included under this field. Owing to rapid advances experienced by this sector, a distinct biologic therapeutics market has formed. This market is mainly being driven by a rising demand for better healthcare treatments occurring all
Biologic Therapeutics Market Geographical Outlook by 2025
Global Biologic Therapeutics Market: Overview The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues. Biological products are used to prevent diseases, diagnose diseases, or treat or cure medical conditions. Global Biologic Therapeutics Market: Key Trends and Opportunities First and foremost,
Human Hepatitis B Immunoglobulin (IM) Market 2017 - Shanghai RAAS, Hualan Biolog …
Apex Research, recently published a detailed market research study focused on the "Human Hepatitis B Immunoglobulin (IM) Market" across the global, regional and country level. The report provides 360° analysis of "Human Hepatitis B Immunoglobulin (IM) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Hepatitis B Immunoglobulin (IM) industry, and
Global Biologic Drugs Sales Market Report 2017
In this report, the global Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast),